Early research (Phase 1)Study completedNCT05148962What this trial is testingStudy of GRT-R910 COVID-19 Boost Vaccine in Healthy VolunteersWho this might be right forCOVID-19 Gritstone bio, Inc. 45
Early research (Phase 1)Not Yet RecruitingNCT07077369What this trial is testingWGc-0201 Plus Tislelizumab in HCC With High Risk of Recurrence and Metastasis After Radical TherapyWho this might be right forHepatocellular Carcinoma (HCC) West China Hospital 10
Early research (Phase 1)WithdrawnNCT05609045What this trial is testingA Phase 1, Randomised, Double-blinded, Placebo-controlled, Dose-escalation Study to Evaluate the Safety and Immunogenicity of RH109 as BoosterWho this might be right forCOVID-19 Pandemic Wuhan Rhegen Biotechnology Co., Ltd.
Large-scale testing (Phase 3)Study completedNCT04652102What this trial is testingA Phase 2b/3, Randomized, Observer-Blinded, Placebo-Controlled, Multicenter Clinical Study Evaluating the Efficacy and Safety of Investigational SARS-CoV-2 mRNA Vaccine CVnCoV in Adults 18 Years of Age and OlderWho this might be right forCovid19SARS-CoV-2 CureVac 39,680
Large-scale testing (Phase 3)Study completedNCT06374394What this trial is testingA Study on the Immune Response and Safety of a Vaccine Against Respiratory Syncytial Virus (RSV) When Given Alone and Together With a COVID-19 mRNA Vaccine in Adults Aged 50 Years and AboveWho this might be right forRespiratory Syncytial Virus Infections GlaxoSmithKline 841
Not applicableUnknownNCT05745545What this trial is testingClinical Trial of COVID-19 Vaccine（SARS-CoV-2 Variant(Omicron BA.5) mRNA Vaccine） in Participants Aged 18 Years and OverWho this might be right forSARS-CoV-2 AIM Vaccine Co., Ltd. 3,200
Large-scale testing (Phase 3)Study completedNCT06279871What this trial is testingImmunogenicity and Safety Study of Self-amplifying mRNA COVID-19 Vaccine Administered With Influenza Vaccines in AdultsWho this might be right forCOVID-19 Arcturus Therapeutics, Inc. 1,514
Early research (Phase 1)Active Not RecruitingNCT06564194What this trial is testingEvaluate JCXH-108, an mRNA-based Vaccine Against RSVWho this might be right forRespiratory Syncytial Virus (RSV)Infectious Disease Immorna Biotherapeutics, Inc. 75
Early research (Phase 1)Not Yet RecruitingNCT07757802What this trial is testingPhase 1 Study of CH505 HIV Vaccine Nanoparticles and mRNA Boosters in Healthy AdultsWho this might be right forHIV National Institute of Allergy and Infectious Diseases (NIAID) 54
Testing effectiveness (Phase 2)Study completedNCT06431607What this trial is testingFind the Dose and Assess the Immune Response and Safety of a Vaccine Against Influenza in Healthy Younger and Older AdultsWho this might be right forInfluenza, Human GlaxoSmithKline 845
Early research (Phase 1)Looking for participantsNCT07694557What this trial is testingEvaluate the Safety, Reactogenicity and Immunogenicity of YKYY025 InjectionWho this might be right forRespiratory Syncytial Virus (RSV) Beijing Youcare Kechuang Pharmaceutical Technology Co., Ltd. 180
Testing effectiveness (Phase 2)Study completedNCT00846456What this trial is testingSafe Study of Dendritic Cell (DC) Based Therapy Targeting Tumor Stem Cells in GlioblastomaWho this might be right forGlioblastomaBrain Tumor Oslo University Hospital 20
Early research (Phase 1)Study completedNCT06375512What this trial is testingDescribe the Safety, Reactogenicity, and Immunogenicity of Herpes Zoster IN001 mRNA Vaccine (IN001) in Healthy ParticipantsWho this might be right forHerpes Zoster Shenzhen Shenxin Biotechnology Co., Ltd 150
Not applicableUnknownNCT05483725What this trial is testingImmunological Safety and Effectiveness of the First Booster Dose of mRNA Vaccines Against COVID-19 in Kidney Transplant Recipients.Who this might be right forKidney DiseasesKidney Transplant; ComplicationsCOVID-19+3 more Institute for Clinical and Experimental Medicine 108
Early research (Phase 1)Looking for participantsNCT07100210What this trial is testingA Clinical Trial Evaluating IL-22BP/LNP Compound in Refractory Malignant Solid Tumors for Safety, Tolerability and ActivityWho this might be right forRefractory Malignant Solid TumorsmRNA VaccineInterleukin Xingchen Peng 6
Early research (Phase 1)Active Not RecruitingNCT06645665What this trial is testingDescribe the Safety and Immunogenicity of a Respiratory Syncytial Virus Vaccine IN006 in Healthy Adult Aged 18 Years and AboveWho this might be right forRespiratory Syncytial Virus Infections Shenzhen Shenxin Biotechnology Co., Ltd 240
Not applicableUnknownNCT04961502What this trial is testingHumoral and Cellular Responses to Vaccination Against Coronavirus Disease 2019 (COVID-19) in the Very Elderly Living in Geriatric InstitutionsWho this might be right forElderly People Institutionalized in Long-term Care Services Gérond'if 80
Not applicableStudy completedNCT04881396What this trial is testingResponse of Haemodialysis Patients to BNT162b2 mRNA Cov-19 VaccineWho this might be right forCOVID-19 VaccinesHemodialysis Complication Hospices Civils de Lyon 99
Large-scale testing (Phase 3)Study completedNCT05925127What this trial is testingPhase 2/3 Heterologous Boosting Study With Different Dose Levels of Monovalent SARS-CoV-2 rS VaccinesWho this might be right forCOVID-19 Novavax 994
Very early researchNot Yet RecruitingNCT07563023What this trial is testingExploratory Study on the Treatment of EB Virus Positive HIV Associated Lymphoma With EBV mRNA VaccineWho this might be right forHIV Associated Lymphoma West China Hospital 6